Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the

Abdul Basit Baba1, Ramesh Nivetha1, Indranil Chattopadhyay2

  • 1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.

Insights

Blueberries and malvidin inhibit the STAT-3 pathway, a key factor in oral cancer development. Combining them with other inhibitors enhances their anticancer effects, offering new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Oncology
  • Nutraceuticals

Background:

  • Blueberries are rich in anthocyanins and recognized for health benefits, including anticancer properties.
  • STAT-3 is an oncogenic transcription factor implicated in various cancers, making it a therapeutic target.

Purpose of the Study:

  • To investigate the potential of blueberries and malvidin in targeting the JAK/STAT-3 pathway in oral cancer.
  • To elucidate the mechanisms by which blueberry and malvidin exert anticancer effects.

Main Methods:

  • Assessment of blueberry and malvidin effects on the JAK/STAT-3 pathway in a hamster model of oral oncogenesis.
  • Mechanistic studies in the oral cancer cell line SCC131, including analysis of STAT-3 phosphorylation and nuclear translocation.
  • Evaluation of combination therapy with blueberry, malvidin, and the STAT-3 inhibitor S3I-201.

Main Results:

  • Blueberry abrogates the JAK/STAT-3 pathway and modulates downstream targets in oral oncogenesis.
  • Blueberry and malvidin inhibit STAT-3 phosphorylation and nuclear translocation in oral cancer cells.
  • Combination therapy with blueberry, malvidin, and S3I-201 showed enhanced STAT-3 inhibition.

Conclusions:

  • Blueberry and its constituent malvidin act as STAT-3 inhibitors, inducing cell cycle arrest and apoptosis.
  • Combination of blueberry and malvidin with STAT-3 inhibitors presents a promising strategy for oral cancer therapy.
  • This study provides a basis for developing novel STAT-3 signaling inhibitors for cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.1K